Multiple Myeloma: Extension of Approval for subcutaneous Administration of Daratumumab

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / 7-8期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：397 / 397
页数：1
相关论文
共 50 条
  • [31] Daratumumab: Beyond Multiple Myeloma
    Ejaz, Kiran
    Roback, John D.
    Stowell, Sean R.
    Sullivan, Harold C.
    [J]. TRANSFUSION MEDICINE REVIEWS, 2021, 35 (03) : 36 - 43
  • [32] Daratumumab for untreated multiple myeloma
    Stirrups, Robert
    [J]. LANCET ONCOLOGY, 2018, 19 (02): : E80 - E80
  • [33] Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma
    Sanchez, Larysa
    Richter, Joshua
    Cho, Hearn Jay
    Jagannath, Sundar
    Madduri, Deepu
    Parekh, Samir
    Richard, Shambavi
    Tam, Lowena
    Verina, Daniel
    Chari, Ajai
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [34] Velcade® licensed in the UK for subcutaneous administration in multiple myeloma patients
    Lake, Francesca
    [J]. FUTURE ONCOLOGY, 2012, 8 (12) : 1512 - 1512
  • [35] The safety of daratumumab for the treatment of multiple myeloma
    Cejalvo, Maria J.
    Ribas, Paz
    de la Rubia, Javier
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (06) : 753 - 760
  • [36] Daratumumab improves survival in multiple myeloma
    Baker, Holly
    [J]. LANCET ONCOLOGY, 2016, 17 (11): : E480 - E480
  • [37] Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Dimopoulos, M. A.
    Oriol, A.
    Nahi, H.
    San-Miguel, J.
    Bahlis, N. J.
    Usmani, S. Z.
    Rabin, N.
    Orlowski, R. Z.
    Komarnicki, M.
    Suzuki, K.
    Plesner, T.
    Yoon, S. -S.
    Ben Yehuda, D.
    Richardson, P. G.
    Goldschmidt, H.
    Reece, D.
    Lisby, S.
    Khokhar, N. Z.
    O'Rourke, L.
    Chiu, C.
    Qin, X.
    Guckert, M.
    Ahmadi, T.
    Moreau, P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (14): : 1319 - 1331
  • [38] Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
    Palumbo, Antonio
    Chanan-Khan, Asher
    Weisel, Katja
    Nooka, Ajay K.
    Masszi, Tamas
    Beksac, Meral
    Spicka, Ivan
    Hungria, Vania
    Munder, Markus
    Mateos, Maria V.
    Mark, Tomer M.
    Qi, Ming
    Schecter, Jordan
    Amin, Himal
    Qin, Xiang
    Deraedt, William
    Ahmadi, Tahamtan
    Spencer, Andrew
    Sonneveld, Pieter
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (08): : 754 - 766
  • [39] Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group
    Vozella, Federico
    Siniscalchi, A.
    Rizzo, M.
    Za, T.
    Antolino, G.
    Coppetelli, U.
    Piciocchi, A.
    Andriani, A.
    Annibali, O.
    De Rosa, L.
    Cimino, G.
    La Verde, G.
    De Stefano, V.
    Cantonetti, M.
    di Toritto, T. Caravita
    Petrucci, M. T.
    [J]. ANNALS OF HEMATOLOGY, 2021, 100 (04) : 1059 - 1063
  • [40] Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group
    Federico Vozella
    A. Siniscalchi
    M. Rizzo
    T. Za
    G. Antolino
    U. Coppetelli
    A. Piciocchi
    A. Andriani
    O. Annibali
    L. De Rosa
    G. Cimino
    G. La Verde
    V. De Stefano
    M. Cantonetti
    T. Caravita di Toritto
    M. T. Petrucci
    [J]. Annals of Hematology, 2021, 100 : 1059 - 1063
12345